Indivior Pharmaceuticals Inc
INDV
Rangering i aksjer
#3881
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aksjekurs
$34.01
Sist synkronisert: 2026-10-19
Markedsverdi
$4.24B
Endring (1 dag)
4.81%
Endring (1 år)
40.02%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategori
Healthcare
Inntekter for Indivior Pharmaceuticals Inc (INDV)
Inntekter i Jun 2026 TTM: $393.00M
Ifølge Indivior Pharmaceuticals Inc sine nyeste økonomiske rapporter er selskapets nåværende resultat $393.00M. I 2023 hadde selskapet et resultat på $-149.00M, en nedgang sammenlignet med resultatet i 2022, som var $-89.00M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Indivior Pharmaceuticals Inc fra 2016 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $393.00M | 2,707.14% |
| 2024 | $14.00M | -109.40% |
| 2023 | $-149.00M | 67.42% |
| 2022 | $-89.00M | -146.84% |
| 2021 | $190.00M | -209.83% |
| 2020 | $-173.00M | -196.11% |
| 2019 | $180.00M | -32.21% |
| 2018 | $265.53M | 84.52% |
| 2017 | $143.91M | 60.35% |
| 2016 | $89.75M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 349.00% |
IN
|
